|
PGD-AS Procedure
Couples
who have PGD will undergo an in vitro fertilization (IVF)
cycle to create embryos. Genetic analysis will then be
performed on cells from each embryo prior to transfer into
the woman’s uterus. To analyze an embryo, we biopsy the
embryo around the third day of its development when the
embryo has approximately 6-8 cells. One or two cells are
taken from the embryo. The embryo is incubated until testing
is complete.
The biopsied cells are analyzed using a technique called
fluorescence in-situ hybridization or FISH. This technique
uses probes, small pieces of DNA that are a match for the
chromosomes we want to analyze, to count the chromosomes
present. FISH is the most commonly applied method to
determine the chromosomal constitution of an embryo. In
contrast to karyotyping, it can be used on interphase
chromosomes, so that it can be used on PBs and blastomeres.
The biopsied PBs or blastomeres are first fixed to a
microscope slide and then the cellular material is digested
away leaving the nucleus, which contains the DNA, in a
spread out and decondensed form. These cells are then
hybridised with DNA probes, labeled with different
fluorochromes. Each of these probes are specific for part of
a chromosome; they will only attach to their exact DNA match
on a particular chromosome. Excess probe is washed off, and
the cell is examined under the fluorescent microscope. We
then count the number of chromosomes of each type (color)
there are in that cell. The geneticist therefore can
distinguish normal cells from cells with aneuploidy.
Currently, a large panel of probes are available for
different segments of all chromosomes, but the limited
number of different fluorochromes confines the number of
signals that can be analysed simultaneously. The type and
number of probes that are used on a sample depends on the
indication. For sex determination (used for instance when a
PCR protocol for a given X-linked disorder is not
available), probes for the X and Y chromosomes are applied
along with probes for one or more of the autosomes as an
internal FISH control. More probes can be added to check for
aneuploidies, particularly those that could give raise to a
viable pregnancy (such as a trisomy 21). Genoma's PGD
laboratory uses FISH probes for the chromosomes most
commonly found in abnormalities: chromosomes X, Y, 13, 14,
15, 16, 18, 21 and 22. This panel of probes has the
potential of detecting 70% of the aneuploidies found in
spontaneous abortions.
In
order to be able to analyse more chromosomes on the same
sample, up to three consecutive rounds of FISH can be
carried out. In the case of chromosome rearrangements,
specific combinations of probes have to be chosen that flank
the region of interest.
Testing of the cells destroys them because they must be
glued to a glass slide and repeatedly heated and cooled. As
such, one cannot use them for another purpose or return them
to the embryo. The slides are kept for future reference.
This analysis causes no extra inconvenience to the patient
as it is accomplished in one day.
The FISH technique is considered to have an error rate
between 5 and 10%. The main problem of the use of FISH to
study the chromosomal constitution of embryos is the
elevated mosaicism rate observed at the human
preimplantation stage. Sandalinas and collaborators found
that up to 70% of the embryos they studied by FISH were
mosaic for some kind of chromosomal abnormality (Sandalinas
et al., 2001). Li and co-workers (2005) found that 40% of
the embryos diagnosed as aneuploid on day 3 turned out to
have a euploid inner cell mass at day 6. Staessen and
collaborators found that 17.5% of the embryos diagnosed as
abnormal during PGS, and subjected to post-PGD reanalysis,
were found to also contain normal cells, and 8.4% were found
grossly normal (Staessen et al., 2004). As a consequence, it
has been questioned whether the one or two cells studied
from an embryo are actually representative of the complete
embryo, and whether viable embryos are not being discarded
due to the limitations of the technique.
Next :
Establishing a diagnosis
 |
 |
|